This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (93)  • Contact me when this article is cited  Related Content  • Related letters  • Related articles  • Similar articles in JAMA  Topic Collections  • Gastrointestinal Diseases  • Surgical Interventions  • Colorectal Surgery  • Oncology  • Colon Cancer  • Alert me on articles by topic

Scientific Review

Judith M. E. Walsh, MD, MPH; Jonathan P. Terdiman, MD

JAMA. 2003;289:1288-1296.

Context  Screening for colorectal cancer clearly reduces colorectal cancer mortality, yet many eligible adults remain unscreened. Several screening tests are available, and various professional organizations have differing recommendations on which screening test to use. Clinicians are challenged to ensure that eligible patients undergo colorectal cancer screening and to guide patients in choosing what tests to receive.

Objective  To critically assess the evidence for use of the available colorectal cancer screening tests, including fecal occult blood tests, sigmoidoscopy, colonoscopy, double-contrast barium enema, and newer tests, such as virtual colonoscopy and stool-based molecular screening.

Data Sources  All relevant English-language articles were identified using PubMed (January 1966-August 2002), published meta-analyses, reference lists of key articles, and expert consultation.

Data Extraction  Studies that evaluated colorectal cancer screening in healthy individuals and assessed clinical outcomes were included. Evidence from randomized controlled trials was considered to be of highest quality, followed by observational evidence. Diagnostic accuracy studies were evaluated when randomized controlled trials and observational studies were not available or did not provide adequate evidence. Studies were excluded if they did not evaluate colorectal screening tests and if they did not evaluate average-risk individuals.

Data Synthesis  Randomized controlled trials have shown that fecal occult blood testing can reduce colorectal cancer incidence and mortality. Case-control studies have shown that sigmoidoscopy is associated with a reduction in mortality, and observational studies suggest colonoscopy is effective as well. Combining fecal occult blood testing and sigmoidoscopy may decrease mortality and can increase diagnostic yield.

Conclusion  The recommendation that all men and women aged 50 years or older undergo screening for colorectal cancer is supported by a large body of direct and indirect evidence. At present, the available evidence does not currently support choosing one test over another.

Author Affiliations: Division of General Internal Medicine, Departments of Medicine and Epidemiology and Biostatistics (Dr Walsh) and Division of Gastroenterology, Department of Medicine (Dr Terdiman), University of California, San Francisco.

RELATED LETTERS

Screening for Colorectal Cancer
Gabriel E. Feldman, Colin W. McCord, Mary T. Bassett, and Thomas R. Frieden
JAMA. 2003;290(2):191.
EXTRACT | FULL TEXT  

Screening for Colorectal Cancer
Neil Schlackman
JAMA. 2003;290(2):191.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Colorectal Cancer Screening: Clinical Applications
Judith M. E. Walsh and Jonathan P. Terdiman
JAMA. 2003;289(10):1297-1302.
ABSTRACT | FULL TEXT  

Colon Cancer Screening
Janet M. Torpy, Cassio Lynm, and Richard M. Glass
JAMA. 2003;289(10):1334.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effects of Socioeconomic Status and Treatment Disparities in Colorectal Cancer Survival
Le et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1950-1962.
ABSTRACT | FULL TEXT  

Commentary: Controversies in NICE guidance on irritable bowel syndrome
Talley
BMJ 2008;336:558-559.
FULL TEXT  

The Surgeon's Role in Cancer Prevention. The Model in Colorectal Carcinoma
Chu et al.
Ann. Surg. Oncol. 2007;14:3054-3069.
ABSTRACT | FULL TEXT  

Blood Markers for Early Detection of Colorectal Cancer: A Systematic Review
Hundt et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1935-1953.
ABSTRACT | FULL TEXT  

A Comparison of Unsedated Colonoscopy and Flexible Sigmoidoscopy in the Family Medicine Setting: An LA Net Study
Knox et al.
J Am Board Fam Med 2007;20:444-450.
ABSTRACT | FULL TEXT  

Reproducibility and reliability of the ankle--brachial index as assessed by vascular experts, family physicians and nurses
Holland-Letz et al.
Vasc Med 2007;12:105-112.
ABSTRACT  

TGF-{beta} signaling alterations and susceptibility to colorectal cancer
Xu and Pasche
Hum Mol Genet 2007;16:R14-R20.
ABSTRACT | FULL TEXT  

Altered Expression and Localization of Creatine Kinase B, Heterogeneous Nuclear Ribonucleoprotein F, and High Mobility Group Box 1 Protein in the Nuclear Matrix Associated with Colon Cancer
Balasubramani et al.
Cancer Res. 2006;66:763-769.
ABSTRACT | FULL TEXT  

COX-2: A Molecular Target for Colorectal Cancer Prevention
Brown and DuBois
JCO 2005;23:2840-2855.
ABSTRACT | FULL TEXT  

Molecular Imaging in the Clinical Arena
Jaffer and Weissleder
JAMA 2005;293:855-862.
ABSTRACT | FULL TEXT  

Patient Education for Colon Cancer Screening: A Randomized Trial of a Video Mailed before a Physical Examination
Zapka et al.
ANN INTERN MED 2004;141:683-692.
ABSTRACT | FULL TEXT  

Colorectal Adenomas: A Prototype for the Use of Surrogate End Points in the Development of Cancer Prevention Drugs
Kelloff et al.
Clin. Cancer Res. 2004;10:3908-3918.
FULL TEXT  

American Cancer Society Guidelines for the Early Detection of Cancer, 2004
Smith et al.
CA Cancer J Clin 2004;54:41-52.
ABSTRACT | FULL TEXT  

Dark lumen magnetic resonance colonography: comparison with conventional colonoscopy for the detection of colorectal pathology
Ajaj et al.
Gut 2003;52:1738-1743.
ABSTRACT | FULL TEXT  

OTHER ARTICLES NOTED (25 Apr 2003 to 18 Jul 2003)
Evid. Based Nurs. 2003;6:e1-12.
FULL TEXT  

Screening for Colorectal Cancer
Feldman et al.
JAMA 2003;290:191-191.
FULL TEXT  

Screening for Colorectal Cancer
Schlackman
JAMA 2003;290:191-191.
FULL TEXT  

Colorectal Polyps
Colucci et al.
Clin Med Res 2003;1:261-262.
FULL TEXT